The Risk of Epilepsy after Long-term Proton Pump Inhibitor Therapy

Chih Sung Liang, Ya Mei Bai, Ju Wei Hsu, Kai Lin Huang, Nai Ying Ko, Chia Kuang Tsai, Ta Chuan Yeh, Hsuan Te Chu, Shih Jen Tsai, Tzeng Ji Chen, Mu Hong Chen

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Background: Prescription-event monitoring studies have reported incident epilepsy or seizures in proton pump inhibitor (PPI) recipients. We examined the risk of epilepsy after prolonged PPI exposure and determine what age group was at higher risk of epilepsy. Methods: We performed a case-control study nested within a sample of Taiwan National Health Insurance beneficiaries (n = 1,000,000). PPI users with subsequent epilepsy were selected as the case cohort. Controls were PPI users without subsequent epilepsy, matched for age, sex, PPI use indication, enrollment time, end point time, follow-up period, overall systemic health, and comorbidities. The total dose of PPI was defined as the cumulative defined daily dose (cDDD). Prolonged PPI use was defined as a cDDD > 365. A logistic regression analysis was performed. Population attributable risk was calculated. Results: Epilepsy occurred 4.13 years after the initiation of PPI use. PPI users with the highest risk of incident epilepsy received a cDDD > 365 [odds ratio = 1.63, 95% confidence interval = 1.37–1.95], followed by 121–365 cDDD (1.33, 1.18–1.51) and 31–120 cDDD (1.15, 1.02–1.29), compared to those receiving a cDDD ≤ 30, after adjusting for potential confounders. Prolonged PPI use increased the risk of epilepsy in all age groups, and the risk was highest for those older than 80 years (3.11, 1.67–5.79). The population attributable risk was 12.2% (> 365 cDDD vs ≤ 30 cDDD). Discussion: Prolonged PPI therapy was associated with an increased risk of epilepsy, particularly in the elderly population.

Original languageEnglish
Pages (from-to)88-93
Number of pages6
Publication statusPublished - 2021 Apr

All Science Journal Classification (ASJC) codes

  • Neurology
  • Clinical Neurology


Dive into the research topics of 'The Risk of Epilepsy after Long-term Proton Pump Inhibitor Therapy'. Together they form a unique fingerprint.

Cite this